These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 38280033)
41. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR. Vaidya KS; Mitten MJ; Zelaya-Lazo AL; Oleksijew A; Alvey C; Falls HD; Mishra S; Palma J; Ansell P; Phillips AC; Reilly EB; Anderson M; Boghaert ER J Neurooncol; 2021 Apr; 152(2):233-243. PubMed ID: 33517558 [TBL] [Abstract][Full Text] [Related]
42. Quercetin induces MGMT Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151 [TBL] [Abstract][Full Text] [Related]
43. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863 [TBL] [Abstract][Full Text] [Related]
44. BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. Čančer M; Drews LF; Bengtsson J; Bolin S; Rosén G; Westermark B; Nelander S; Forsberg-Nilsson K; Uhrbom L; Weishaupt H; Swartling FJ Cell Death Dis; 2019 Nov; 10(12):881. PubMed ID: 31754113 [TBL] [Abstract][Full Text] [Related]
45. Metformin treatment reduces temozolomide resistance of glioblastoma cells. Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206 [TBL] [Abstract][Full Text] [Related]
47. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494 [TBL] [Abstract][Full Text] [Related]
48. Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells. Kaina B; Beltzig L; Piee-Staffa A; Haas B Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977591 [TBL] [Abstract][Full Text] [Related]
49. Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres. Oh HC; Shim JK; Park J; Lee JH; Choi RJ; Kim NH; Kim HS; Moon JH; Kim EH; Chang JH; Yook JI; Kang SG J Cancer Res Clin Oncol; 2020 Nov; 146(11):2817-2828. PubMed ID: 32712753 [TBL] [Abstract][Full Text] [Related]
50. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells. Zhang X; Ni Q; Wang Y; Fan H; Li Y Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900 [TBL] [Abstract][Full Text] [Related]
51. Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma. Yadav A; Alnakhli A; Vemana HP; Bhutkar S; Muth A; Dukhande VV Pharm Res; 2022 Nov; 39(11):2871-2883. PubMed ID: 36195821 [TBL] [Abstract][Full Text] [Related]
52. The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells. Serafino A; Krasnowska EK; Romanò S; De Gregorio A; Colone M; Dupuis ML; Bonucci M; Ravagnan G; Stringaro A; Fuggetta MP Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408901 [TBL] [Abstract][Full Text] [Related]
53. Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells. Sun Y; Zhang X Anat Rec (Hoboken); 2019 Nov; 302(11):1950-1957. PubMed ID: 31177611 [TBL] [Abstract][Full Text] [Related]
54. Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas. Kratzsch T; Kuhn SA; Joedicke A; Hanisch UK; Vajkoczy P; Hoffmann J; Fichtner I J Cancer Res Clin Oncol; 2018 May; 144(5):809-819. PubMed ID: 29427211 [TBL] [Abstract][Full Text] [Related]
55. BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction. Yao Z; Yang S; Zhao H; Yang H; Jiang X Cancer Gene Ther; 2020 Apr; 27(3-4):226-234. PubMed ID: 30518782 [TBL] [Abstract][Full Text] [Related]
56. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244 [TBL] [Abstract][Full Text] [Related]